PharmiWeb

Rocket Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Highlights Recent Progress

Pivotal Phase 2 trial of RP-A501 for Danon disease to resume in 1H 2026KRESLADI™ for severe LAD-I on track for March 28, 2026 ...
PharmiWeb

Lineage Cell Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results and Provide Business Update on March 5, 2026

LCTX #LineageCellTherapeutics--Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology ...
PharmiWeb

Globe Business and Aeris Launch IoT Accelerator Platform in the Philippines

Strategic Alliance Enables Rapid Growth and Scale of Connected Vehicles and Enterprises Through IoTA Connectivity Management ...
PharmiWeb

Uniphar | Clinical and BMclinical Join Forces to Elevate Clinical Trial Services

Clinical and BMclinical have merged to offer an expanded global clinical trial supply service, enhancing sourcing, packaging, ...
PharmiWeb

UHG TAKE PRIVATE ANNOUNCEMENT: United Homes Group, Inc. Shareholders are Notified of BFA Law’s Investigation into UHG’s Announced $1.18 per share Take Private Transaction

Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into United Homes Group, Inc.’s (NASDAQ: UHG) board of directors for potential breaches of their fiduciary duties to ...
PharmiWeb

Puma Biotechnology Reports Fourth Quarter and Full Year 2025 Financial Results

Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced financial results for the fourth quarter and year ended December 31, 2025. Unless otherwise stated, all comparisons are ...
PharmiWeb

Neurogene Announces FDA Breakthrough Therapy Designation for NGN-401 Gene Therapy for Rett Syndrome

Breakthrough Therapy designation granted based on interim NGN-401 Phase 1/2 data demonstrating clinically meaningful, durable and multidomain functional improvementsOn track to complete dosing in ...
PharmiWeb

Qure.ai Nets Six New Indications Cleared by the FDA, Taking the Chest X-ray Crown in the Radiology AI Race

Latest solution identifies, highlights & categorizes key positive findings to support clinicians, taking total FDA cleared indications to 26NEW YORK--(BUSINESS WIRE)--The US Food and Drug ...
PharmiWeb

MCW Investigation Alert: Mister Car Wash, Inc. Board is being Investigated Following $7 Take Private Deal – Contact BFA Law Regarding Your Rights

Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Mister Car Wash, Inc.’s (NASDAQ: MCW) board of directors and its controlling stockholder, LGP, for potential ...
PharmiWeb

Vir Biotechnology to Participate in Upcoming Investor Conferences

Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that members of the management team will participate in the following investor conferences during the month of March:TD Cowen 46th Annual Health ...
PharmiWeb

PLUG Court Alert: Plug Power Inc. Investors Bring Securities Fraud Class Action Following DOE Funding Issues – Contact BFA Law by April 3 Deadline

Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Plug Power Inc. (NASDAQ:PLUG) and certain of the Company’s senior executives for ...
PharmiWeb

CRWV Court Alert: CoreWeave, Inc. Investors Bring Securities Fraud Class Action After Infrastructure Delays – Contact BFA Law by March 13 Deadline

Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against CoreWeave, Inc. (NASDAQ:CRWV) and certain of the Company’s senior executives for ...